Post Tagged with: "European Society for Medical Oncology"

Sustaining Cancer Care Through Collaborative Stewardship

Sustaining Cancer Care Through Collaborative Stewardship

European Medical Journal, Oncology November 30, 2017 at 8:27 AM 0 comments

This symposium took place on 9th September 2017, as part of the European Society for Medical Oncology (ESMO) meeting in Madrid, Spain Chairperson: Matti Aapro1 Speakers: Muir Gray,2 Geoffrey Henning,3 Matti Aapro,1 Jatinder Harchowal,4 Bengt Jönsson5 1. Multidisciplinary Oncology Institute, Genolier, Switzerland 2. Better Value Healthcare, Oxford, UK 3. EuropaColon,Read More

State-of-the-Art Integration of Multiple Kinase Inhibitors in the Treatment of Gastrointestinal Cancers

State-of-the-Art Integration of Multiple Kinase Inhibitors in the Treatment of Gastrointestinal Cancers

Oncology November 22, 2016 at 8:29 AM 0 comments

This satellite symposium took place on 4th September 2016 as a part of the European Society of Medical Oncology (ESMO) Congress in Copenhagen, Denmark Chairperson: Axel Grothey1 Speakers: Marc Ychou,2 Jean-Yves Blay,3 Eric Van Cutsem,4 Jordi Bruix5 1. Mayo Clinic, Rochester, Minnesota, USA 2. Montpellier Cancer Institute, Montpellier, France 3.Read More

Optimising Salvage Therapy in Aggressive B Cell Non-Hodgkin Lymphoma

Optimising Salvage Therapy in Aggressive B Cell Non-Hodgkin Lymphoma

Oncology November 22, 2016 at 8:28 AM 0 comments

This symposium took place on 7th October 2016 as a part of the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark Chairpersons: Francesco D’Amore,1 Ruth Pettengell2 Speakers: Pieternella Lugtenburg,3 Ruth Pettengell,2 Pier Luigi Zinzani,4 Raul Cordoba5 1. Aarhus University Hospital, Aarhus, Denmark 2. St George’s, University ofRead More

Cabozantinib as First-Line Therapy for Patients with Metastatic Renal Cell Carcinoma with Poor or Intermediate-Risk Characteristics

Cabozantinib as First-Line Therapy for Patients with Metastatic Renal Cell Carcinoma with Poor or Intermediate-Risk Characteristics

Oncology November 22, 2016 at 8:27 AM 0 comments

This Presidential Symposium took place on 10th October 2016 as a part of the European Society for Medical Oncology (ESMO) Congress in Copenhagen, Denmark Speaker: Toni K. Choueiri Dana-Farber Cancer Institute, Boston, Massachusetts, USA Disclosure: Associate Prof Choueiri has received honoraria for advisory board membership and consultancy from Pfizer, Exelixis,Read More

Regorafenib in Metastatic Colorectal Cancer and Advanced Soft Tissue Sarcomas

Regorafenib in Metastatic Colorectal Cancer and Advanced Soft Tissue Sarcomas

Oncology November 22, 2016 at 8:26 AM 0 comments

Summary of Presentations from the 2016 Meeting of The American Society of Clinical Oncology (ASCO) held in Chicago, Illinois, USA, from 3rd–7th June 2016 Speakers: Eric Van Cutsem,1 Yuji Miaymoto,2 Tanios Bekaii-Saab,3 Nicolas Penel4 1. University Hospitals Leuven, Leuven, Belgium 2. Division of Medical Oncology, USC Norris Comprehensive Cancer Center,Read More